MDSC inhibitors show a significant decrease in the expression of CD4+FOXP3+ on day 3 (p = 0.03 and p = 0.03) in sepsis patients compared to day 0, but no difference was observed in w/o sepsis patients (Supplementary Figure 8C). This evidence concerns the gene FOXP3 and Sepsis.